N/A N=30 Efficacy Evaluation of Using Finger Stick Peripheral Blood for Point of Care Pregnancy Testing
Pregnancy Testing
Primary: Number of Participants With Positive POC Serum Pregnancy Test — 30 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=120 Clearblue Home Pregnancy Test Consumer Study
Pregnancy
Primary: Consumer Agreement — 100 percentage of agreement
N/A N=51 The Role of a Semi-Quantitative Urine Pregnancy Test and Pregnancy Questionnaire After Uterine Evacuation for Undesired Pregnancy of Uncertain Location
Follow-up After Uterine Evacuation
Primary: Number of Women in Each Group Who Require a Return Visit to the Clinic for a Serum hCG Measurement, Ultrasound or Clinical Examination at One Week to Confirm Complete…
N/A N=4,488 National Prevalence and Impact of Noninvasive Prenatal Testing
Aneuploidy
Primary: Number of Patient Undergoing IDTFK Before (Control) and After (Test) NIPT Testing Came to Market — 1414; 3074 Participants
N/A N=38 Pilot Testing a New Pregnancy Decision Making Tool for Women With Physical Disabilities
Disability Physical
Primary: Final Decisional Conflict Scale Score - Values Clarity Sub-scale — 13.1 units on a scale
N/A N=500 Study of the Sensitivity of Manual vs Electric Aspiration to Detect Completed Early Abortion
Induced Abortion
Primary: Accurate Confirmation of Completed Abortion — 182; 164 participants — p=.13
N/A N=150 Psychological Impact of Pregnancy of Unknown Location
Pregnancy of Unknown Location · Ectopic Pregnancy · Anxiety
Primary: Psychological Morbidity — 10; 10; 5; 5 score on a scale
N/A N=20 Innovations in HIV Testing (TI)
Human Immunodeficiency Virus
Primary: Qualitative Summaries of Participant Experience in Focus Group Discussions — 100; 7; 26; 10 number of times reported in FGD
N/A N=281 HIV Testing Strategies in the Perinatal Setting
HIV Infections · Pregnancy Related
Primary: Satisfaction With HIV Testing Experience (O'Connor Decisional Conflict Scale) — 16.0; 19.9 scores on scale
N/A N=106 Postpartum Pre-exposure Prophylaxis (PrEP) Study to Evaluate an Adherence Promotion Package for Postpartum Women on PrEP
HIV-1-infection
Primary: Recent PrEP Adherence — 33; 18 Participants — p=<0.001
N/A N=151 Evaluating the Safety of PregSense™ and Compare Its Performance to CTG in Prenatal Monitoring of Pregnant Subjects
Pregnancy
Primary: Fetal Heart Rate — 140.3; 140.4 bpm
N/A N=2,454 Testing Implementation Strategies to Improve Delivery of PrEP for Pregnant and Postpartum Women in Kenya
Pre-Exposure Prophylaxis · HIV Infections · Pregnancy Related
Primary: Change in PrEP Penetration — 13; 23; 35; 3 Participants
N/A N=23 Pilot Testing A Pregnancy Decision Making Tool for Women With Spinal Cord Injury (SCI)
Spinal Cord Injuries · Pregnancy Related
Primary: Final Decisional Conflict Scale Score - Values Clarity Sub-scale — 13.4 units on a scale
Phase 4 N=284 Penicillin Allergy Testing in STD Clinics
Penicillin Allergy
Primary: Number of Respondents Who Responded YES to Any Question Defining High Risk Penicillin Allergy Using Questionnaire Developed by the Study — 36; 36 Participants
N/A N=736 HIV Self Testing of Male Partners of Women in PMTCT
ART Adherence · PMTCT · Linkage to Care
Primary: Proportion of Men Who Test for HIV in the Self-test Arm to Men Who Test for HIV in the Standard of Care Arm — 161; 75 participants
N/A N=200 Male Partner Engagement in HIV Testing Using Partner-notification Slip Plus Oral HIV Self-testing Kit
HIV Infections
Primary: Proportion of Male Partners Who Reported to Clinic — 0.38; 0.32 proportion of male partners
N/A N=83 FreeStyle Libre in Pregnancy Study
Diabetes Mellitus
Primary: Point Accuracy Determined as % Within Consensus Error Grid Zone A — 88.1 percentage of results
N/A N=100 Point-of-care Urine Monitoring of Adherence: Testing a Real-Time Urine Assay of Tenofovir in PrEP
Risk Reduction
Primary: Long-term Adherence Metrics Via Hair Concentrations of Tenofovir and Short-term Adherence Metric of Urine Concentrations of Tenofovir. — 33; 26; 31; 19 Participants
N/A N=341 Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women
HIV
Primary: Number of Participants Who Reported Primary Male Partner Completed HIV Testing at a Healthcare Facility — 3; 15; 3; 33 Participants
Phase 2 N=57 Correlation of Continuous Glucose Monitoring and Glucose Tolerance Testing With Pregnancy Outcomes
Diabetes, Gestational
Primary: Correlation Between Glucose AUC and Birth Weight. — 0.2902; 0.2935; 0.2915; 0.2859 correlation coefficient — p=0.035
N/A N=20 Patient Centered Postpartum Contraception App
Contraceptive Usage
Primary: Feasibility of Application — 4.47; 4.52; 4.16; 4.26 units on a scale
N/A N=11 HSG and Tubal Patency Study
Tubal Patency
Primary: Number of Participants With Bilateral Tubal Patency as Assessed by HSG-follicular — 9; 1 Participants — p=0.4795
Phase 3 N=255 Optimal Treatment for Women With a Persisting Pregnancy of Unknown Location
Persistent Pregnancy of Unknown Location · Ectopic Pregnancy
Primary: Number of Participants With Uneventful Clinical Resolution of a Pregnancy of Unknown Location Without Change From the Initial Management Strategy — 31; 42; 45 Participants
Phase 4 N=711 RAPID EC - Rct Assessing Pregnancy With Intrauterine Devices for EC
Contraception
Primary: Percentage of Participants Reporting a Pregnancy — 0; 0.3 % of participants reporting pregnancy
Phase 4 N=50 Advance Supply of Emergency Contraception Compared to Routine Postpartum Care in Teens
Post Partum
Primary: ABILITY TO FOLLOW POSTPARTUM TEENS FOR 1 YEAR. — 22; 16 Participants
N/A N=1,607 Monitoring and Testing of Blood Pressure in Postpartum Women
Hypertension
Primary: Median Number of Remote Blood Pressure (rBPM) Measurements Obtained Per Participant — 6 Number of rBPM measurements
N/A N=13 Evaluation of Novel Point of Care Coagulation System in Pregnant Women
Hemorrhage · Coagulation Delay
Primary: Correlation of Fibrinogen in mg/dL Concentration With Clot Strength (CS hPa) and Fibrinogen Contribution to Clot (FCS hPa) of Point of the Care Quantra System. — 494…
N/A N=32,771 Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial
Uterine Cervical Neoplasm · Uterine Neoplasms · Genital Neoplasms, Female
Primary: Screening Completion by Outreach Approach and Prior Screening Behavior — 3671; 3960; 1482; 3956 Participants — p=0.05
Phase 4 N=15 Effect of hCG on Receptivity of the Human Endometrium
Infertility · Subfertility
Primary: Endometrial Staging in hCG Versus Vehicle Treated Patients — 4.0; 4.6; 3.9; 6.5 days — p=<0.05
N/A N=351 Point of Care Diagnosis of Vaginal Infections
Vaginitis · Bacterial Vaginosis · Yeast Vaginitis
Primary: Number of Participants Prescribed Appropriate Treatment — 61; 104; 58; 21 Participants — p=<.001